Informacje dodatkowe
| Use in sports | Not recognized for performance enhancement in sports |
|---|---|
| Formula | C28H38N6O11S |
| Side effects | Headache, flushing, dyspepsia, nasal congestion, impaired vision, photophobia, and blurred vision |
| Effects | Improves erectile response when a man is sexually stimulated |
| Dosage (sports) | Not typically used in sports for performance enhancement |
| Dosage (medical) | Commonly 50 mg, adjustable between 25 mg to 100 mg depending on efficacy and tolerance |
| Half-life | Approximately 4 hours |
| Main action | Enhances erectile function by increasing blood flow to the penis |
| Substance class | Phosphodiesterase type 5 (PDE5) inhibitor |
| Chemical name | 1-[4-ethoxy-3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)phenylsulfonyl]-4-methylpiperazine citrate |
| Storage conditions | Store at room temperature between 15-30В°C (59-86В°F) in a closed container |
| Trade name | Viagra |
| Blood pressure | Can cause transient decreases in blood pressure |
| Also known as | Viagra, Revatio |
| Lab Test | Detection in blood tests for substances |
| Hepatotoxicity | Low risk |
| Water Retention | None |
| Raw Material | Sildenafil |
| Manufacturer | SP Laboratories |
| Packing | 10 tabs (100mg/tab) |
Opinie
Na razie nie ma opinii o produkcie.